breast cancer

Thanks to modern chemotherapy, gene-targeted therapy, and radiation therapy, there are now over 3.5 million breast cancer survivors in the United States. Each of these treatments, however, may carry an increased risk for major cardiac events and early cardiac death. Fortunately, University of Florida single-institution data indicate that declines in heart function during treatment can be detected through advanced analysis of heart function based on 3D magnetic resonance imaging (MRI).